Agricultural Biologics Market Report 2026

The agricultural biologics market size has grown rapidly in recent years. It will grow from $16.45 billion in 2025 to $19.06 billion in 2026 at a compound annual growth rate (CAGR) of 15.8%. The growth in the historic period can be attributed to rising awareness of sustainable agriculture, increasing regulatory restrictions on chemical pesticides, growth of organic farming acreage, adoption of integrated crop management practices, availability of microbial formulations.

The agricultural biologics market size is expected to see rapid growth in the next few years. It will grow to $33.51 billion in 2030 at a compound annual growth rate (CAGR) of 15.2%. The growth in the forecast period can be attributed to expansion of precision agriculture adoption, rising demand for sustainable yield enhancement solutions, increasing investment in biological R&D, growing acceptance of biological inputs among farmers, innovation in formulation technologies. Major trends in the forecast period include increasing adoption of bio-based crop protection solutions, rising demand for integrated pest management inputs, growing use of microbial-based products, expansion of residue-free farming practices, enhanced focus on soil health improvement.

Increasing investments in research and development are anticipated to drive the growth of the agriculture biologics market. These investments involve allocating funds to foster innovation and create new products or technologies. By enhancing research and development, advancements can be made in agricultural biologics, leading to the creation of new and improved biological products, increased quality and consistency of these products, and reduced costs. For instance, in May 2023, Corteva, Inc., a US-based agricultural chemical company, released the Corteva Research and Development Innovation Update, stating that the company is investing to deliver products necessary for meeting its 2025 financial targets, with expectations for growth to reach $2 billion by 2035 within its biological business. Consequently, the rise in investments in research and development is expected to propel the growth of the agricultural biologics market.

Key players in the agriculture biologics market are placing emphasis on the development of innovative products, such as the ENTAZIATM biofungicide, to fortify their market positions. ENTAZIATM is a biofungicide that can be integrated into FMC's biostimulants and synthetic fungicides within a comprehensive pest control strategy, delivering additional benefits to plants. For instance, in August 2023, FMC Corporation, an India-based agricultural sciences company, introduced ENTAZIATM, a revolutionary biological crop protection solution formulated around Bacillus subtilis. This advanced technology equips farmers with a potent, long-lasting tool for fungus protection while upholding environmental integrity. It not only safeguards farmers' productivity but also contributes to a more environmentally sustainable agricultural ecology, as exemplified by ENTAZIATM biofungicide.

In September 2023, Biobest Group NV, a Belgium-based producer of biological-based crop protection and pollination products, acquired Biotrop for $569.4 million. The acquisition aligns with Biobest's strategy to expand into South American markets, positioning itself as a major provider of biological solutions encompassing biocontrol, biostimulants, and other sustainable crop protection products. Biotrop, based in Brazil, specializes in natural and biological technologies for agricultural applications.

Major companies operating in the agricultural biologics market are Bayer AG, BASF SE, Syngenta AG, Corteva Inc., FMC Corporation, UPL Limited, Novozymes A/S, Chr. Hansen Holding A/S, Valent BioSciences LLC, Certis Biologicals, Koppert Biological Systems, Biobest Group NV, Andermatt Group AG, Marrone Bio Innovations, Isagro S.p.A., T. Stanes and Company Limited, Lallemand Plant Care, Gowan Company, Valagro S.p.A., Rizobacter Argentina S.A., Symborg S.L.

North America was the largest region in the agricultural biologics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the agricultural biologics market. The regions covered in the agricultural biologics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the agricultural biologics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The agricultural biologics market consists of sales of agricultural biologicals from sources such as plant extracts and minerals. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.